Myxoid/Round Cell Liposarcoma
6 clinical trials · Condition
◉ Watch Myxoid/Round Cell Liposarcoma
| Record | Firm | Date |
|---|---|---|
| NY-ESO-1-redirected CRISPR (TCRendo and PD1) Edited T Cells (NYCE T Cells) (NCT03399448) | University of Pennsylvania | 2018-09-05 |
| MAGE-A4ᶜ¹º³²T for Multi-Tumor (NCT03132922) | USWM CT, LLC | 2017-05-15 |
| Study to Compare the Safety and Efficacy of CMB305 With Atezolizumab to Atezolizumab Alone in Participants With Sarcoma (IMDZ-C232/V943A-002) (NCT02609984) | Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2015-04-29 |
| NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma (NCT02059850) | Fred Hutchinson Cancer Center | 2014-07-01 |
Track Myxoid/Round Cell Liposarcoma automatically
Every clearance here is in the API, with alerts when new ones post.